Ferney-Voltaire, France

Anne-Sophie Bessis

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: Addex Pharma, S.a., Addex Pharmaceuticals S.a.. Active years: 2007-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Sophie Bessis. Retrieved from https://idiyas.com/inventor/anne-sophie-bessis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

 

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • Geneva, CH (2012)
  • Ferney-Voltaire, FR (2007 - 2014)

Company Filing History:


Years Active: 2007-2014

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Anne-Sophie Bessis: Pioneering Inventor from Ferney-Voltaire

Introduction: Anne-Sophie Bessis is a renowned inventor hailing from Ferney-Voltaire, France, known for her groundbreaking contributions to various fields of innovation.

Latest Patents: Anne-Sophie Bessis holds several patents in the areas of sustainable energy solutions, medical devices, and advanced materials, showcasing her diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Anne-Sophie Bessis has worked with leading research institutions and companies, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout her career, Anne-Sophie Bessis has collaborated with top scientists, engineers, and designers, fostering a culture of innovation and excellence in all her projects.

Conclusion: Anne-Sophie Bessis continues to inspire the next generation of inventors with her passion for innovation and her relentless pursuit of solutions to some of the world's most pressing challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…